References
To the Article
Scopinaro N, Papadia F, Marinari G et al. Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic divesion in patients with BMI <35 kg/m2. Obes Surg 2007; 17: 185–92.
Sjostrom L, Lindroos AK, Peltonen M et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683–93.
Pories WJ, Swanson MS, MacDonald KG et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339–50; discussion 50–2.
Chan JM, Rimm EB, Colditz GA et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961–9.
Colditz GA, Willett WC, Rotnitzky A et al. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481–6.
Norris SL, Zhang X, Avenell A et al. Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: a meta-analysis. Am J Med 2004; 117: 762–74.
Wing RR, Koeske R, Epstein LH et al. Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med 1987; 147: 1749–53.
O’Brien PE, Dixon JB, Laurie C et al Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med 2006; 144: 625–33.
le Roux CW, Aylwin SJ, Batterham RL et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006; 243: 108–14.
Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004; 239: 1–11.
Mason EE. Ileal transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg 1999; 9: 223–8.
Rubino F, Forgione A, Cummings DE et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006; 244: 741–9.
Cummings DE. Gastric bypass and nesidioblastosis—too much of a good thing for islets? N Engl J Med 2005; 353: 300–2.
To the Invited Commentary
Scopinaro N, Papadia F, Marinari G et al. Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI <35 kg/m2. Obes Surg 2007; 17: 185–92.
Mason EE. Ileal transposition and entero-glucagon/GLP-1 in obesity and (diabetic?) surgery. A review of the literature. Obes Surg 1999; 9: 223–8.
Mason EE. The mechanisms of surgical treatment of type 2 diabetes (Editorial). Obes Surg 2005; 15: 459–61.
Drucker DJ. The role of gut hormones in glucose homeostasis. J Clin Invest 2007; 117: 24–32.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dixon, J.B., O’Brien, P.E. & Mason, E.E. Bariatric Surgery Provides Unparalleled Metabolic Benefits. OBES SURG 17, 193–194 (2007). https://doi.org/10.1007/s11695-007-9046-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-007-9046-x